Corcept Therapeutics logo

Corcept Therapeutics

CORT | NASDAQ
Chart Builder DCF Calculator
$80.69
-$0.43 (-0.53%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
761.41M 675.04M 482.38M 401.86M 365.98M 353.87M
Cost of Revenue
12.98M 10.88M 6.48M 5.39M 5.28M 5.58M
Gross Profit
748.43M 664.16M 475.89M 396.47M 360.7M 348.29M
Operating Income
44.8M 136.95M 107.28M 112.63M 124.48M 128.2M
Interest Income
21.67M 24.54M 17.28M 3.56M 529K 3.4M
Pretax Income
66.46M 161.49M 124.56M 116.19M 125.01M 131.6M
Net Income
99.65M 139.73M 106.14M 101.42M 112.51M 106.01M
Selling & General & Admin
448.73M 280.32M 184.26M 152.85M 122.36M 105.33M
Research & Development
254.91M 246.89M 184.35M 130.99M 113.86M 114.76M
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
703.63M 527.21M 368.61M 283.84M 236.22M 220.09M
Interest Expense
n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
716.61M 538.09M 375.09M 289.22M 241.5M 225.67M
Income Tax Expense
-33.19M 20.28M 18.42M 14.77M 12.49M 25.59M
Shares Outstanding (Basic)
103.86M 103.23M 103.56M 106.79M 115.65M 115.41M
Shares Outstanding (Diluted)
119.99M 113.48M 111.74M 115.97M 125.96M 124.19M
EPS (Basic)
0.95 1.35 1.02 0.95 0.97 0.92
EPS (Diluted)
0.82 1.23 0.94 0.87 0.89 0.85
EBITDA
68.35M 162.83M 125.6M 117.45M 127.95M 130.44M
EBIT
66.46M 161.49M 124.56M 116.19M 125.01M 128.2M
Depreciation & Amortization
1.89M 1.34M 1.04M 1.26M 3.07M 2.24M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.